Michael Healy-Rae (Kerry South, Independent)
Link to this: Individually | In context | Oireachtas source

635. To ask the Minister for Health the progress that has been made or is proposed to be made to reform the Misuse of Drugs Acts to allow a cannabis nasal spray to be sold and used by persons suffering from cancer and brain tumours, and used strictly by persons who are in poor health; and if he will make a statement on the matter. [37487/15]

Aodhán Ó Ríordáin (Dublin North Central, Labour)
Link to this: Individually | In context | Oireachtas source

Under the Misuse of Drugs Acts, 1977 to 2015 and the Regulations made thereunder, the manufacture, production, preparation, sale, supply, distribution and possession of cannabis is currently unlawful except for the purposes of research.

My Department is aware that cannabis for medicinal use has been legalised in some countries and that there have been several studies internationally on the therapeutic effects of cannabinoids for a number of medical issues. Under European and Irish legislation, before a medicine can be placed on the Irish market the manufacturer has to seek an authorisation from the Health Products Regulatory Authority (HPRA) or in the case of certain medicinal products, the European Medicines Agency (EMA). A determination on an application for authorisation of a medicine is based on a rigorous scientific assessment of the application against legal and regulatory requirements.

In July 2014, the Misuse of Drugs Regulations were amended to allow for certain cannabis based medicinal products to be used in Ireland. Subsequently the HPRA granted a marketing authorisation for a cannabis based medicinal product which is indicated for the relief of certain symptoms for people with multiple sclerosis. It is not indicated for use by persons suffering from cancer and brain tumours.

My Department will continue to keep developments in relation to cannabis based medical products under review.